News Room

 

Industry News

Podcast on cancer treatment under the NHI with National Department of Health Acting Director General Dr Anban Pillay....

Samir Khalil, executive director for the Pharmaceutical Research and Manufacturers of America (PhRMA) Middle East and Africa (MEA), reveals why the US industry is investing in MEA, the challenges presented by the lack of intellectual property enforcement in the region, and the shifting of focus from manufacturing to broader research and development....

Achieving #HealthForAll depends on the availability & capacity of #HCPs to deliver quality people-centred integrated care. That’s why countries need to recruit, educate and train practitioners. More policy perspectives from @IFPMA:  https://bit.ly/2DMbCB6...

We’re seeing a growth in new and different types of collaborations to advance access to healthcare. This #UHCDay, discover how @NCDAccess, @gardp_amr, @CCan_org, @CombatNTDs & @FINDdx are tackling some of the biggest challenges in health today: https://bit.ly/35WhYK6 ...

#HealthForAll is about much more than medicine and vaccine innovation - it requires: ⚕️ establishing strong #healthsystems 📋 developing public health education 🌐 strengthening standards and regulations See how our sector contributes to @GlobalHealth: https://bit.ly/38akH4P #UHCDay...

To #KeepThePromise of #HealthForAll, the question is no longer whether the private sector has a role to play in #UHC but rather how best to work with the private sector in delivering it: https://on.ft.com/2DKTmYP via @ft #UHCDay...

Achieving #HealthforAll is only possible when the right stakeholders are engaged. This means leveraging the strengths of civil society, the private sector, academia, local communities & health practitioners. #UHCDay...

In the words of @DrTedros, “#health is the wisest investment a country can make. It enables populations to learn and earn, start businesses and thrive.” Here are 7 ways to better #InvestinHealth: https://bit.ly/2DMbCB6...

With over 200 collaborations, @GlobalHealth details the scope, scale and breadth of collaborations involving our sector to strengthen #healthsystems & expand access to quality healthcare: https://bit.ly/38akH4P #UHCDay...

5 Qs for Dr. Gitahi @daktari1 on #UHCDay: 1⃣How to mobilize more resources for #UHC? 2⃣How to address the shortage of #HCPs? 3⃣How to reduce inefficiencies? 4⃣Is partnership the model for delivering UHC? 5⃣What’s the role of the private sector? ▶️ https://bit.ly/2E1nmQ6 ...

The biopharmaceutical industry has for years been involved in hundreds of partnerships to improve access to both essential and innovative medicines, and continues to be a trusted partner to advance access to healthcare. This #UHCDay, we reiterate our commitment to help countries #KeepThePromise of #HealthForAll. Full article from Thomas Cueni in FT: https://on.ft.com/2DKTmYP Global Health Progress hub: https://bit.ly/38akH4P Policy perspectives on UHC from IFPMA: https://bit.ly/2DMbCB6...

.@_AfricanUnion leaders have shown great leadership on #UHC, says @daktari1. In this Q&A, he argues next steps will be to #InvestInHealth and minimise waste & collaborate with the private sector: https://bit.ly/2E1nmQ6 #KeepThePromise #UHCDay...

This last half century has been witness to dramatic scientific progress in medical care that has yielded great advances in patient outcomes in terms of longevity and quality of life. This article hosted by @guardian explains why #UHC & innovation are interlinked: https://bit.ly/34ZmlnT #UHCDay...

As part of the @UHC2030 movement, the innovative biopharmaceutical industry calls on global leaders to deliver on the Key Asks and to #KeepThePromise of #HealthForAll: https://bit.ly/387sf88  ...

The goal is clear. Now, more than ever, we need to focus our attention on #HealthForAll and pool resources, expertise and experience to make UHC a reality. Our sector is committed for the long-haul: www.globalhealthprogress.org...

Investing in a population’s health pays dividends to entire countries. #HealthforAll is not only the right choice, but the smart choice. #UHCDay #KeepThePromise...

No single organization or sector can achieve #UHC on its own. It will require: 💡 Pooling resources, knowledge and experience 🤝 Establishing meaningful partnerships 🌐 Collaborating in the best interest of #patients, people and the planet. ▶️ https://bit.ly/2DMbCB6 #UHCDay ...

For this year’s #UHCDay, we sat down with Dr Githinji Gitahi, CEO of @Amref_Worldwide & co-chair of @UHC2030, to discuss how governments can #KeepThePromise to achieve #HealthForAll by 2030: https://bit.ly/2E1nmQ6 @daktari1...

To #LeaveNoOneBehind 👩👦👨👦, countries need to foster integrated, multi-sectoral, people-centered approaches to reach every household with a basic package of interventions and manage both infections & chronic conditions across the life course: https://bit.ly/2DMbCB6 #UHCDay...

Countries with much lower per capita GDP have success fully implemented universal health care At the United Nations general assembly in September, all countries, including South Africa, reaffirmed their commitment to achieving universal health coverage by 2030. This is achieved when everybody accesses the health......

Parliament’s portfolio commit tee on health will only consider how to manage the vast volume of written submissions it has received in response to the national health insurance (NHI) bill in February, says committee chair Sibongiseni Dhlomo....

The private sec tor price for a basket of 13 commonly prescribed medicines is 53.7% less than the global median Business Day · 21 Nov 2019 · Tamar Kahn Science & Health Writer kahnt@businesslive.co.za Medicine prices in SA are the sixth lowest of 50 countries......

#AMR is one of the biggest global health threats to date – the need for new antibiotics is beyond question. New economic models that address the current market failure in antibiotic research are urgently needed @ThomasCueni @IFPMA http://bit.ly/2ozsEOU #AMR could cost the global economy $100......

To tackle today’s biggest global health challenges, we need robust, holistic partnerships across all sectors and political prioritization in-country. @ThomasCueni’s insights on why investing in #UHC is the smartest economic choice: http://bit.ly/2NsBW7x   The @UN declaration on UHC was a milestone for the global health......

An innovative approach to the NHI can deliver universal healthcare that offers real equity in access and treatment outcomes. Read the full article here...

See how our industry contributes to the development of harmonized norms and standards that enable an adequate quality, safety, and efficacy control of medical products globally...

This #WorldHealthDay, @IFPMA highlights that health is a sound investment in human capital, making individuals, communities and economies thrive....

This #WorldHealthDay join us in spreading the word that quality #healthcare and #UHC brings well-being to families, enables children to learn and adults to earn 🙌🏿🏥🌍📈...

Investing in #UHC is an investment in #people, a country’s most valued asset....

What does it take to make #UHC truly “universal”? #WorldHealthDay ...

Globally, over 2.7 billion women, mothers and adolescent girls are legally denied access to education, jobs and most importantly healthcare. In some countries they still cannot access health services without spousal or parental permission. There is no doubt that women bear the brunt of health inequities. A holistic approach around ‘smart economics’ is needed to address this gap. ...

The role that pharmaceutical companies play in improving the health and welfare of the general population is one that is often overlooked. Not only do their medicines save lives, improve health, and prolong and enhance the quality of life, but medicines also have the potential to reduce overall healthcare costs by speeding up recovery times, as well as the need for surgery and hospitalisation....

Xolani Gwala hosted the second edition of #Change4Cancer. Joining him was a panel of various stakeholders who looked at the many answered questions related to the disease. They looked at matters relating to access to quality treatment, early screening and detection, behavioural change and alternative......

Please see the document below for the new appointments to the executive board of IPASA. IPASA New EXCO Release 12 November 2018...

Draft IP Policy – Phase I IPASA Cover Letter 171117 NHI Implementation Structure – IPASA Submission 20171130 NHI Implementation Structures – IPASA Cover Letter POPI Regulations – IPASA Comments 171107 POPI Regulations – IPASA Cover Letter Revised Draft IP Policy – IPASA Narrative Submission 171117......

Media Release 2019

Colleen Purdy is the Amgen GM for South Africa. She joined Amgen in 2012 and was tasked with setting up and establishing an affiliate based in Johannesburg. Prior to this Colleen worked in various commercial roles in South Africa for Batswadi, Janssen, Schering-Plough, Madaus and......

Daniel Binette has been appointed Managing Director of Lilly South Africa. His career at Lilly spans 18 years where 15 were spent in Canada in various commercial roles. He is known as a strategic, dynamic, customer focused and results-oriented leader with multiple launch experiences. Before......

Thierry Brule Joined AbbVie South Africa as General Manager for South Africa and Region Africa in 2018. He has 15 years of industry experience across multiple functions, across major Therapeutic Areas (from Oncology, Hematology, Neonatology and Immunology to Virology, Respiratory and Ophthalmology), in Europe, in......

Rhulani Nhlaniki is the Cluster Lead for Sub-Saharan Africa and Country Manager for South Africa at Pfizer. He joined Pfizer in 2016 in the role Innovative Health Cluster Lead for the Sub-Saharan Africa. He has over 18 years’ experience in the pharmaceutical industry where he......

On behalf of Novartis, I am deeply saddened to inform you of the passing of Dr. Mo Kawa, CEO & Country President for Novartis South Africa. He passed away peacefully on Monday, 7 October after a brave battle with cancer....

Media Release 2018

Erika Koppers joined Shire as Country Lead, South Africa in November 2016 to establish the legal entity and set up operations as Shire Pharmaceuticals SA. Prior to joining Shire, Erika worked at AstraZeneca and Roche covering various commercial roles with local and Sub-Sahara responsibilities across......

Emma Knox joined GSK UK in 2004. She has held a variety of roles in Sales, Marketing and Market Access across Europe, Emerging Market and more recently in Southern Africa. She moved to South Africa in 2012 where she took on the role of Marketing......

Thibault Crosnier_Leconte joined Sanofi South Africa in 2016 as the Country Chair and RX General Manager for South Africa, Namibia & Botswana. He has 17 years of industry experience, which includes leadership positions at Sanofi in the UK and in Russia, where he served as......

Media Release 2017

Media Release 2014